FDA Extends Comment Period for Proposed Rule to Revoke Authorized Health Claim Regarding Soy Protein and Coronary Heart Disease
January 12, 2018
The U.S. Food and Drug Administration is providing an additional 60 days for public comment on the agency’s proposed rule to revoke the authorized health claim on the relationship between soy protein and reduced risk of coronary heart disease. The FDA published the proposed rule, “Food Labeling: Health Claims; Soy Protein and Coronary Heart Disease,” on October 31, 2017. The FDA is extending the comment period in response to requests from stakeholders for additional time.
The comment period will now close on March 19, 2018.
To submit comments to the docket electronically, visit http://www.regulations.gov and type FDA-2017-N-0763 in the search box.
To submit comments to the docket by mail, use the following address.
Please be sure to include docket number FDA-2017-N-0763 on each page of your written comments.
Dockets Management Staff
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, MD 20852
- Federal Register Notice Announcing the Comment Period Extension
- Proposed Rule: Food Labeling: Health Claims; Soy Protein and Coronary Heart Disease
- Statement from Susan Mayne, Ph.D., on proposal to revoke health claim that soy protein reduces risk of heart disease